Welcome to our dedicated page for Astera Labs SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astera Labs filings document a Nasdaq-listed semiconductor connectivity company serving rack-scale AI infrastructure. The company’s Form 8-K reports cover quarterly and annual operating results, product and demand commentary tied to PCIe 6, Scorpio smart fabric switches, signal conditioning and Smart Cable Modules, and material business updates.
ALAB regulatory disclosures also record its common stock listing on the Nasdaq Global Select Market, emerging growth company status, executive officer appointments and compensation arrangements, and material definitive agreements, including customer-linked warrant terms. Proxy materials describe annual meeting proposals, board elections, auditor ratification, executive compensation votes and stockholder voting mechanics.
Astera Labs (ALAB) Form 4 reports two consecutive insider sales by CEO & Director Jitendra Mohan on 17-18 Jul 2025 pursuant to a Rule 10b5-1 plan adopted 2 Dec 2024.
- 17 Jul 2025: 80,503 common shares sold through six estate-planning trusts at a weighted-average price of $94.37.
- 18 Jul 2025: 45,755 common shares sold through the same trusts at a weighted-average price of $100.25.
Total disposition: 126,258 shares (~1 % of reported holdings). Post-sale beneficial ownership remains substantial at roughly 9.8 million shares, including 2.26 million held directly and 7.54 million held indirectly across multiple trusts.
No derivative activity was disclosed. Because the sales were automatic and represent a small fraction of total ownership, they appear to be routine liquidity events; however, investors may monitor future filings for additional insider trends.